Akute intermittierende Porphyrie

Givosiran als neue therapeutische Option

Gastro-News volume 8, pages14–15(2021)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

1

Literatur

  1. 1.

    Montgomery D et al. N Engl J Med 2017;377(9):862-72

  2. 2.

    Sardh E et al. N Engl J Med 2019 Feb 7;380(6):549-58

  3. 3.

    G-BA. Arzneimittel-Richtlinie/Anlage XII: Givosiran 15.10.2020

  4. 4.

    Alnylam Netherlands B.V. Fachinformation Givosiran 2020

Download references

Author information

Affiliations

  1. Klinik für GastroenterologiMedizinische Hochschule Hannover, Klinik f. Gastroenterologie und Hepatologie - Zentrum Innere Medizin, Carl-Neuberg-Straße 1, 30625, Hannover, Germany

    Prof. Dr. med. Heiner Wedemeyer

  2. Medizinische Hochschule Hannover, Klinik f. Gastroenterologie und Hepatologie - Zentrum Innere Medizin, Carl-Neuberg-Straße 1, 30625, Hannover, Germany

    PD Dr. med. Katja Deterding

  3. Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Hannover, Germany

    Dr. med. Tammo L. Tergast

Authors
  1. Prof. Dr. med. Heiner Wedemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PD Dr. med. Katja Deterding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. med. Tammo L. Tergast
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Prof. Dr. med. Heiner Wedemeyer or PD Dr. med. Katja Deterding.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wedemeyer, H., Deterding, K. & Tergast, T. Givosiran als neue therapeutische Option. Gastro-News 8, 14–15 (2021). https://doi.org/10.1007/s15036-020-2280-y

Download citation